CMC(SH:603122) Zheng Quan Shi Bao Wang·2025-11-05 01:59Group 1 - The stock of HeFu China (603122) has hit the daily limit up for seven consecutive trading days, currently priced at 13.04 yuan per share with over 200,000 hands on the limit up board [1] - The company issued a risk warning stating that its main business has not undergone significant changes, and the recent stock price surge may be due to overheated market sentiment and irrational speculation, significantly deviating from the company's fundamentals [1] - The company's current price-to-earnings (P/E) ratio is 171.11 times, which is substantially higher than the industry average P/E ratio of 28.90 times, indicating a risk of severe deviation from reasonable valuations [1] Group 2 - In Q3 2025, the company reported a net profit attributable to shareholders of -5.048 million yuan, a decline of 225.26% year-on-year, primarily due to changes in the domestic macroeconomic environment and price reductions from centralized procurement policies in the medical industry [2] - The decrease in product procurement prices for hospital clients, along with a reduction in order volumes compared to the previous year, has led to a decline in both sales revenue and profit levels [2] - Although the company has implemented several cost control measures, the short-term reduction in expenses has not fully offset the decline in revenue, resulting in pressure on short-term operating performance and potential earnings volatility [2]